BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18688034)

  • 1. Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo.
    de Ostrovich KK; Lambertz I; Colby JK; Tian J; Rundhaug JE; Johnston D; Conti CJ; DiGiovanni J; Fuchs-Young R
    Am J Pathol; 2008 Sep; 173(3):824-34. PubMed ID: 18688034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental stage determines estrogen receptor alpha expression and non-genomic mechanisms that control IGF-1 signaling and mammary proliferation in mice.
    Tian J; Berton TR; Shirley SH; Lambertz I; Gimenez-Conti IB; DiGiovanni J; Korach KS; Conti CJ; Fuchs-Young R
    J Clin Invest; 2012 Jan; 122(1):192-204. PubMed ID: 22182837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.
    Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT
    Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prepubertal exposure to cow's milk reduces susceptibility to carcinogen-induced mammary tumorigenesis in rats.
    Nielsen TS; Khan G; Davis J; Michels KB; Hilakivi-Clarke L
    Int J Cancer; 2011 Jan; 128(1):12-20. PubMed ID: 20232392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis.
    Dearth RK; Kuiatse I; Wang YF; Liao L; Hilsenbeck SG; Brown PH; Xu J; Lee AV
    BMC Cancer; 2011 Aug; 11():377. PubMed ID: 21867536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis.
    Bagheri-Yarmand R; Talukder AH; Wang RA; Vadlamudi RK; Kumar R
    Development; 2004 Jul; 131(14):3469-79. PubMed ID: 15226262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.
    Wang A; Arantes S; Yan L; Kiguchi K; McArthur MJ; Sahin A; Thames HD; Aldaz CM; Macleod MC
    BMC Cancer; 2008 Sep; 8():268. PubMed ID: 18808719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion.
    DiGiovanni J; Bol DK; Wilker E; Beltrán L; Carbajal S; Moats S; Ramirez A; Jorcano J; Kiguchi K
    Cancer Res; 2000 Mar; 60(6):1561-70. PubMed ID: 10749124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway.
    Thordarson G; Slusher N; Leong H; Ochoa D; Rajkumar L; Guzman R; Nandi S; Talamantes F
    Breast Cancer Res; 2004; 6(4):R423-36. PubMed ID: 15217511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.
    Teulière J; Faraldo MM; Deugnier MA; Shtutman M; Ben-Ze'ev A; Thiery JP; Glukhova MA
    Development; 2005 Jan; 132(2):267-77. PubMed ID: 15590737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
    Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
    Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of ovine insulin-like growth factor-1 (IGF-1) stimulates alveolar bud development in mammary glands of transgenic mice.
    Weber MS; Boyle PL; Corl BA; Wong EA; Gwazdauskas FC; Akers RM
    Endocrine; 1998 Jun; 8(3):251-9. PubMed ID: 9741830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERα)-positive mammary adenocarcinomas.
    Mukherjee M; Ge G; Zhang N; Edwards DG; Sumazin P; Sharan SK; Rao PH; Medina D; Pati D
    Oncogene; 2014 Nov; 33(48):5511-5522. PubMed ID: 24276237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
    Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
    Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urothelial overexpression of insulin-like growth factor-1 increases susceptibility to p-cresidine-induced bladder carcinogenesis in transgenic mice.
    Hursting SD; Perkins SN; Lavigne JA; Beltran L; Haines DC; Hill HL; Alvord WG; Barrett JC; DiGiovanni J
    Mol Carcinog; 2009 Aug; 48(8):671-7. PubMed ID: 19415693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands.
    Tian J; Lambertz I; Berton TR; Rundhaug JE; Kiguchi K; Shirley SH; Digiovanni J; Conti CJ; Fischer SM; Fuchs-Young R
    Mol Carcinog; 2012 Dec; 51(12):973-83. PubMed ID: 22006370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.
    Guerra FK; Eijan AM; Puricelli L; Alonso DF; Bal de Kier Joffé E; Kornblihgtt AR; Charreau EH; Elizalde PV
    Int J Cancer; 1996 Mar; 65(6):812-20. PubMed ID: 8631597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors.
    Liao DZ; Pantazis CG; Hou X; Li SA
    Carcinogenesis; 1998 Dec; 19(12):2173-80. PubMed ID: 9886575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma.
    Tilli MT; Frech MS; Steed ME; Hruska KS; Johnson MD; Flaws JA; Furth PA
    Am J Pathol; 2003 Nov; 163(5):1713-9. PubMed ID: 14578170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.
    Herynk MH; Lewis MT; Hopp TA; Medina D; Corona-Rodriguez A; Cui Y; Beyer AR; Fuqua SA
    Oncogene; 2009 Sep; 28(36):3177-87. PubMed ID: 19561644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.